Article Details

Registrational Trial of AFM13 Will Continue Following Success of Preplanned Interim Analysis

Retrieved on: 2021-03-11 18:56:15

Tags for this article:

Click the tags to see associated articles and topics

Registrational Trial of AFM13 Will Continue Following Success of Preplanned Interim Analysis. View article details on hiswai:

Excerpt

These data reinforce our strategy to broadly develop AFM13 across CD30-positive lymphomas both as monotherapy and in combination with other ...

Article found on: www.cancernetwork.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up